POC Molecular Diagnostics Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025 - Market Research Engine The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global POC Molecular Diagnostics market share. Major industry players with significant revenue share include Johnson & Johnson, Danaher Corp, Cepheid, Inc, Bio-Rad Laboratories, Inc, biomatrix, Becton, Dickinson and Company, Hoffmann-La Roche AG, Bayer HealthCare Pharmaceuticals LLC, and others. The global point-of-care molecular diagnostics market size is anticipated to reach US$ 3.86 Billion by 2024 increasing at a CAGR of 14.4% in the given forecast period. Browse Full Report: https://www.marketresearchengine.com/poc-moleculardiagnostics-market The global POC Molecular Diagnostics market is segregated on the basis of Application as Infectious Diseases, Oncology, Hematology, Prenatal Testing, and Endocrinology. Based on Technology the global POC Molecular Diagnostics market is segmented in PCR-based, Genetic Sequencing-based, Hybridization-based, and Microarray-based. Based on End Use the global POC Molecular Diagnostics market is segmented in Decentralized Labs, Hospitals, Homecare, and Assisted Living Healthcare Facilities. The global POC Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The POC Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others. Ongoing research & development to miniaturize molecular diagnostics testing that provides increased near patient testing with high accuracy and lesser turnaround times are major factors expected to reinforce the high growth potential for POC products. Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help order a treatment in the first instance without having to wait for final results. Competitive Rivalry Johnson & Johnson, Danaher Corp, Cepheid, Inc, Bio-Rad Laboratories, Inc, biomatrix, Becton, Dickinson and Company, Hoffmann-La Roche AG, Bayer HealthCare Pharmaceuticals LLC, and others are among the major players in the global POC Molecular Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain. The POC Molecular Diagnostics Market has been segmented as below: POC Molecular Diagnostics Market, By Application  
Infectious Diseases Oncology